Dual‐photon microscopy‐based quantitation of fibrosis‐related parameters (q‐FP) to model disease progression in steatohepatitis

There is a need for further refinement of current histological systems for assessment of hepatic fibrosis in nonalcoholic fatty liver disease (NAFLD). This study evaluated hepatic fibrosis in NAFLD using dual‐photon microscopy‐based quantitation of fibrosis‐related parameters (q‐FPs). Fifty test coh...

Full description

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 65; no. 6; pp. 1891 - 1903
Main Authors Wang, Yan, Vincent, Robert, Yang, Jinlian, Asgharpour, Amon, Liang, Xieer, Idowu, Michael O., Contos, Melissa J., Daitya, Kalyani, Siddiqui, Mohammed S., Mirshahi, Faridoddin, Sanyal, Arun J.
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health, Inc 01.06.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:There is a need for further refinement of current histological systems for assessment of hepatic fibrosis in nonalcoholic fatty liver disease (NAFLD). This study evaluated hepatic fibrosis in NAFLD using dual‐photon microscopy‐based quantitation of fibrosis‐related parameters (q‐FPs). Fifty test cohort subjects and 42 validation cohort subjects with NAFLD and the full spectrum of fibrosis were studied. q‐FPs were measured in specific predefined regions of interest (general, vessel, perisinusoid, and vascular septa). Seventy q‐FPs had inter‐ and intraobserver concordance ≥0.8 and were related to the NASH Clinical Research Network fibrosis staging. Of these, 16 q‐FPs with the strongest correlations (P < 0.001 for all) were entered in a principal component analysis model (odds ratio [OR] 7.8, P < 0.001), which separated any stage of fibrosis versus no fibrosis, and cirrhosis versus earlier stages with the areas under the receiver operating characteristic curves of 0.88 and 0.93 (P ≤ 0.01 for both), respectively. In an independent multivariable analysis, four q‐FPs—the number of collagen strands (OR 8.5, P = 0.004), strand length (OR 12.0, P = 0.02), strand eccentricity (OR 8.3, P = 0.004), and strand solidity (OR 8.0, P = 0.003)—were independently associated with fibrosis stages and were used to model fibrosis along a continuous linear scale using desirability functions; this linear scale of fibrosis measurement was also related to fibrosis stage (P < 0.0001). The robustness of both the multivariable model and the linear scale of measurement was confirmed in the validation cohort. Conclusion: The q‐FP model provides an accurate reproducible method to evaluate fibrosis in NAFLD along a quantitative and continuous scale. (Hepatology 2017;65:1891‐1903).
Bibliography:This work was supported by National Institutes of Health Grants T32 DK 61731, RO1 AA020758, RO1 DK 10596 (to A.J.S.); Natural Science Foundation of China Grants 81371603 and 81670522 (to Y.W.); and Guangdong Science and Technology Plan Project 2013B051000051 (to Y.W.).
Potential conflict of interest: Amon Asgharpour consults for and owns stock in SanyalBio. Arun J. Sanyal is President of Sanyal Biotechnology and has stock options in Genfit. He has served as a consultant to AbVie, Astra Zeneca, Nitto Denko, Nimbus, Salix, Tobira, Takeda, Fibrogen, Lilly, Zafgen, Novartis, Pfizer, Immuron, Exhalenz, and Genfit. He has been an unpaid consultant to Intercept, Echosens, Immuron, Amarin, Ardelyx, Fractyl, Syntlogic, Nordic Bioscience and Bristol Myers Squibb. His institution has received grant support from Gilead, Salix, Tobira, Intercept, Merck, Astra Zeneca and Novartis.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
Senior author: Arun J. Sanyal, MBBS, MD, Professor of Medicine, Physiology and Molecular Pathology, MCV Box 980341, Richmond, VA 23298-0341, arun.sanyal@vcuhealth.org, Phone: (804) 828 6314, Fax: (804) 828 2992
Primary author: Yan Wang, MD, PhD, Professor of Medicine and Bioengineering, Dept. of Infectious Diseases & Hepatology Unit, Southern Medical University Nanfang Hospital, No 1838 Guangzhou Dadao Bei Avenue, GZ China 510515, yanwang@smu.edu.cn, +8620 6164 7396
ISSN:0270-9139
1527-3350
1527-3350
DOI:10.1002/hep.29090